IllnessCarbohydrate metabolism disorders, differential diagnosis
Summary
Comprehensive differential diagnostic panel for Oligosaccharidoses comprising altogether 114 curated genes according to the clinical signs
202,0 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
[Sanger]
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
AGA | 1041 | NM_000027.4 | AR | |
ALDOB | 1095 | NM_000035.4 | AR | |
CTSA | 1497 | NM_000308.4 | AR | |
FUCA1 | 1401 | NM_000147.5 | AR | |
GALT | 1140 | NM_000155.4 | AR | |
MAN2B1 | 3036 | NM_000528.4 | AR | |
MANBA | 2640 | NM_005908.4 | AR | |
NAGA | 1236 | NM_000262.3 | AR | |
NEU1 | 1248 | NM_000434.4 | AR | |
ABCC8 | 4746 | NM_000352.6 | AD, AR | |
AGL | 4599 | NM_000642.3 | AR | |
AGPAT2 | 837 | NM_006412.4 | AR | |
AGXT | 1179 | NM_000030.3 | AR | |
AKT2 | 1446 | NM_001626.6 | AD | |
ALDOA | 1095 | NM_184041.5 | AR | |
APPL1 | 2129 | NM_012096.3 | AD | |
ARSB | 1602 | NM_000046.5 | AR | |
BSCL2 | 1197 | NM_032667.6 | AR | |
CA5A | 918 | NM_001739.2 | AR | |
CISD2 | 408 | NM_001008388.5 | AR | |
DCAF17 | 1563 | NM_025000.4 | AR | |
DCXR | 729 | NM_001195218.1 | AR | |
DNAJC3 | 1515 | NM_006260.5 | AR | |
DYRK1B | 1890 | NM_004714.3 | AD | |
EIF2AK3 | 3351 | NM_004836.7 | AR | |
EIF2S3 | 1419 | NM_001415.4 | XLR | |
ENO3 | 1305 | NM_053013.4 | AR | |
FBP1 | 1017 | NM_000507.4 | AR | |
FOXP3 | 1296 | NM_014009.4 | XLR | |
G6PC1 | 1074 | NM_000151.4 | AR | |
GAA | 2859 | NM_000152.5 | AR | |
GALE | 1047 | NM_000403.4 | AR | |
GALK1 | 1179 | NM_000154.2 | AR | |
GALNS | 1569 | NM_000512.5 | AR | |
GATA4 | 1329 | NM_002052.5 | AD | |
GATA6 | 1788 | NM_005257.6 | AD | |
GBE1 | 2109 | NM_000158.4 | AR | |
GCK | 1398 | NM_000162.5 | AD, AR | |
GK | 1575 | NM_000167.6 | XLR | |
GLB1 | 2034 | NM_000404.4 | AR | |
GLIS3 | 2328 | NM_152629.4 | AR | |
GLYCTK | 705 | NM_001144951.2 | AR | |
GNS | 1659 | NM_002076.4 | AR | |
GPI | 1677 | NM_000175.5 | AR | |
GRHPR | 987 | NM_012203.2 | AR | |
GYG1 | 1053 | NM_004130.4 | AR | |
GYS1 | 2022 | NM_001161587.2 | AR | |
GYS2 | 2112 | NM_021957.4 | AR | |
HGSNAT | 1908 | NM_152419.3 | AR | |
HNF1A | 1896 | NM_000545.8 | AD | |
HNF1B | 1674 | NM_000458.4 | AD | |
HNF4A | 1359 | NM_175914.4 | AD | |
HOGA1 | 984 | NM_138413.4 | AR | |
IDS | 1653 | NM_000202.8 | XL | |
IDUA | 1962 | NM_000203.5 | AR | |
IER3IP1 | 249 | NM_016097.5 | AR | |
IL2RA | 819 | NM_000417.3 | AR | |
INS | 333 | NM_000207.3 | AD, AR | |
INSR | 4149 | NM_000208.4 | AD, AR | |
KCNJ11 | 1173 | NM_000525.4 | AD, AR | |
KHK | 897 | NM_000221.3 | AR | |
LAMP2 | 1233 | NM_002294.3 | XL | |
LCT | 5784 | NM_002299.4 | AR | |
LDHA | 999 | NM_005566.4 | AR | |
LMNA | 1995 | NM_170707.4 | AD | |
LRBA | 8556 | NM_001199282.2 | AR | |
NAGLU | 2232 | NM_000263.4 | AD, AR | |
NEUROD1 | 1071 | NM_002500.5 | AD, AR | |
NEUROG3 | 645 | NM_020999.4 | AR | |
NKX2-2 | 822 | NM_002509.4 | AR | |
PAX6 | 1269 | NM_000280.5 | AD | |
PC | 3537 | NM_000920.4 | AR | |
PCBD1 | 315 | NM_000281.4 | AR | |
PCK1 | 1869 | NM_002591.4 | AR | |
PDX1 | 852 | NM_000209.4 | AR | |
PFKM | 2343 | NM_000289.6 | AR | |
PGAM2 | 762 | NM_000290.4 | AR | |
PGK1 | 1254 | NM_000291.4 | XLR | |
PGM1 | 1743 | NM_002633.3 | AR | |
PHKA1 | 3633 | NM_002637.4 | XLR | |
PHKA2 | 3708 | NM_000292.3 | XLR | |
PHKB | 3282 | NM_000293.3 | AR | |
PHKG2 | 1221 | NM_000294.3 | AR | |
PIK3R1 | 2175 | NM_181523.3 | AD | |
PLIN1 | 1569 | NM_002666.5 | AD | |
POLD1 | 3324 | NM_002691.4 | AD | |
PPARG | 1518 | NM_015869.5 | AD | |
PPP1R15B | 2142 | NM_032833.5 | AR | |
PTF1A | 987 | NM_178161.3 | AR | |
PYGL | 2544 | NM_002863.5 | AR | |
PYGM | 2529 | NM_005609.4 | AR | |
RBCK1 | 1407 | NM_006462.6 | AR | |
RFX6 | 2787 | NM_173560.4 | AR | |
RPIA | 936 | NM_144563.3 | AR | |
SGSH | 1509 | NM_000199.5 | AR | |
SI | 5484 | NM_001041.4 | AR | |
SLC16A1 | 1503 | NM_003051.4 | AD, AR | |
SLC19A2 | 1494 | NM_006996.3 | AR | |
SLC29A3 | 1428 | NM_018344.6 | AR | |
SLC2A1 | 1479 |
| NM_006516.4 | AD, AR |
SLC2A2 | 1575 | NM_000340.2 | AR | |
SLC37A4 | 1291 | NM_001164277.2 | AR, AD | |
SLC5A1 | 1995 | NM_000343.4 | AR | |
SLC5A2 | 2019 | NM_003041.4 | AD, AR | |
STAT3 | 2313 | NM_139276.3 | AD | |
TALDO1 | 1014 | NM_006755.2 | AR | |
TPI1 | 750 | NM_000365.6 | AR | |
TRMT10A | 1020 | NM_001134665.3 | AR | |
WFS1 | 2673 | NM_006005.3 | AR | |
ZBTB20 | 2226 | NM_001164342.2 | AD | |
ZFP57 | 1611 | NM_001109809.5 | AD | |
ZMPSTE24 | 1428 | NM_005857.5 | AR |
Informations about the disease
Group of diseases
- Alias: Oligosaccharidoses
- Allelic: Agammaglobulinemia 7, (AR (PIK3R1)
- Allelic: Aniridia (PAX6)
- Allelic: Anterior segment dysgenesis 5, multiple subtypes (PAX6)
- Allelic: Atrial septal defect 2 (GATA4)
- Allelic: Atrial septal defect 9 (GATA6)
- Allelic: Atrioventricular septal defect 4 (GATA4)
- Allelic: Atrioventricular septal defect 5 (GATA6)
- Allelic: Autoimmune disease, multisystem, infantile-onset, 1 (STAT3)
- Allelic: Cardiomyopathy, dilated, 1A (LMNA)
- Allelic: Carotid intimal medial thickness 1 (PPARG)
- Allelic: Cataract 41 (WFS1)
- Allelic: Cataract with late-onset corneal dystrophy (PAX6)
- Allelic: Charcot-Marie-Tooth disease, axonal, type 2V (NAGLU)
- Allelic: Charcot-Marie-Tooth disease, type 2B1 (LMNA)
- Allelic: Coloboma of optic nerve (PAX6)
- Allelic: Coloboma, ocular (PAX6)
- Allelic: Colorectal cancer, susceptibility to, 1 (POLD1)
- Allelic: Deafness, AD 6/14/38 (WFS1)
- Allelic: Emery-Dreifuss muscular dystrophy 2, AD (LMNA)
- Allelic: Emery-Dreifuss muscular dystrophy 3, AR (LMNA)
- Allelic: Foveal hypoplasia 1 (PAX6)
- Allelic: Heart-hand syndrome, Slovenian type (LMNA)
- Allelic: Hyper-IgE recurrent infection syndrome (STAT3)
- Allelic: Immunodeficiency 36 (PIK3R1)
- Allelic: Keratitis (PAX6)
- Allelic: Mandibuloacral dysplasia (LMNA)
- Allelic: Morning glory disc anomaly (PAX6)
- Allelic: Muscular dystrophy, congenital (LMNA)
- Allelic: Optic nerve hypoplasia (PAX6)
- Allelic: Persistent truncus arteriosus (GATA6)
- Allelic: Renal cell carcinoma (HNF1A, HNF1B)
- Allelic: Restrictive dermopathy, lethal (LMNA)
- Allelic: Restrictive dermopathy, lethal (ZMPSTE24)
- Allelic: Retinitis pigmentosa 73 (HGSNAT)
- Allelic: Testicular anomalies withwithout congenital heart disease (GATA4)
- Allelic: Tetralogy of Fallot (GATA4, GATA6)
- Allelic: Ventricular septal defect 1 (GATA4)
- Abdominal obesity-metabolic syndrome (DYRK1B)
- Aspartylglucosaminuria (AGA)
- Ataxia, combined cerebellar + peripheral, with hearing loss + diabetes mellitus (DNAJC3)
- Congenital disorder of glycosylation, type IIw (SLC37A4)
- Congenital disorder of glycosylation, type It (PGM1)
- Currarino syndrome (MNX1)
- D-glyceric aciduria (GLYCTK)
- Danon disease (LAMP2)
- Diabetes [panelapp] (PAX6)
- Diabetes mellitus, insulin-dependent (HNF1A)
- Diabetes mellitus, insulin-dependent, 2 (INS)
- Diabetes mellitus, insulin-dependent, 20 (HNF1A)
- Diabetes mellitus, insulin-resistant + acanthosis nigricans (INSR)
- Diabetes mellitus, neonatal, with congenital hypothyroidism (GLIS3)
- Diabetes mellitus, noninsulin-dependent (ABCC8)
- Diabetes mellitus, noninsulin-dependent (HNF4A)
- Diabetes mellitus, noninsulin-dependent (SLC2A2)
- Diabetes mellitus, noninsulin-dependent, 2 (HNF1A)
- Diabetes mellitus, noninsulin-dependent, association with (WFS1)
- Diabetes mellitus, noninsulin-dependent, late onset (GCK)
- Diabetes mellitus, permanent neonatal 1 (GCK)
- Diabetes mellitus, permanent neonatal 3, +/- neurologic features (ABCC8)
- Diabetes mellitus, permanent neonatal 4 (INS)
- Diabetes mellitus, transient neonatal 1 (ZFP57)
- Diabetes mellitus, transient neonatal 2 (ABCC8)
- Diabetes mellitus, transient neonatal 3 (KCNJ11)
- Diabetes mellitus, type 2, susceptibility to (KCNJ11)
- Diabetes mellitus, type II (AKT2)
- Diabetes mellitus, type II, susceptibility to (PDX1)
- Diabetes, mellitus, insulin-dependent, susceptibility to, 10 (IL2RA)
- Diabetes, permanent neonatal 2, with or without neurologic features (KCNJ11)
- Diabetes, type 2 (PPARG)
- Diarrhea 4, malabsorptive, congenital (NEUROG3)
- Dystonia 9 (SLC2A1)
- Encephalopathy, progressive, +/- lipodystrophy (BSCL2)
- Epilepsy, idiopathic generalized, susceptibility to, 12 (SLC2A1)
- Erythrocyte lactate transporter defect (SLC16A1)
- Fanconi renotubular syndrome 4, with maturity-onset diabetes of the young (HNF4A)
- Fanconi-Bickel syndrome (SLC2A2)
- Fructose intolerance, hereditary (ALDOB)
- Fructose-1,6-bisphosphatase deficiency (FBP1)
- Fructosuria (KHK)
- Fucosidosis (FUCA1)
- GLUT1 deficiency syndrome 1, infantile onset, severe (SLC2A1)
- GLUT1 deficiency syndrome 2, childhood onset (SLC2A1)
- GM1-gangliosidosis, type I (GLB1)
- GM1-gangliosidosis, type II (GLB1)
- GM1-gangliosidosis, type III (GLB1)
- Galactokinase deficiency with cataracts (GALK)
- Galactose epimerase deficiency (GALE)
- Galactosemia (GALT)
- Galactosialidosis (CTSA)
- Glucose/galactose malabsorption (SLC5A1)
- Glycerol kinase deficiency (GK)
- Glycogen storage disease 0, liver (GYS2)
- Glycogen storage disease 0, muscle (GYS1)
- Glycogen storage disease II (GAA)
- Glycogen storage disease IIIa (AGL)
- Glycogen storage disease IIIb (AGL)
- Glycogen storage disease IV (GBE1)
- Glycogen storage disease IXc (PHKG2)
- Glycogen storage disease Ia (G6PC1)
- Glycogen storage disease Ib (SLC37A4)
- Glycogen storage disease Ic (SLC37A4)
- Glycogen storage disease VI (PYGL)
- Glycogen storage disease VII (PFKM)
- Glycogen storage disease X (PGAM2)
- Glycogen storage disease XI (LDHA)
- Glycogen storage disease XII (ALDOA)
- Glycogen storage disease XIII (ENO3)
- Glycogen storage disease XV (GYG1)
- Glycogen storage disease, type IXa1 (PHKA2)
- Glycogen storage disease, type IXa2 (PHKA2)
- Hemolytic anemia due to triosephosphate isomerase deficiency (TPI1)
- Hemolytic anemia, nonspherocytic, due to glucose phosphate isomerase deficiency (GPI)
- Histiocytosis-lymphadenopathy plus syndrome (SLC29A3)
- Hutchinson-Gilford progeria (LMNA)
- Hyperammonemia due to carbonic anhydrase VA deficiency (CA5A)
- Hyperinsulinemic hypoglycemia, familial, 1 (ABCC8)
- Hyperinsulinemic hypoglycemia, familial, 2 (KCNJ11)
- Hyperinsulinemic hypoglycemia, familial, 3 (GCK)
- Hyperinsulinemic hypoglycemia, familial, 5 (INSR)
- Hyperinsulinemic hypoglycemia, familial, 7 (SLC16A1)
- Hyperoxaluria, primary, type 1 (AGXT)
- Hyperoxaluria, primary, type II (GRHPR)
- Hyperoxaluria, primary, type III (HOGA1)
- Hyperphenylalaninemia, BH4-deficient, D (PCBD1)
- Hyperproinsulinemia (INS)
- Hypoglycemia of infancy, leucine-sensitive (ABCC8)
- Hypoinsulinemic hypoglycemia with hemihypertrophy (AKT2)
- Immunodeficiency 41 with lymphoproliferation + autoimmunity (IL2RA)
- Immunodeficiency, common variable, 8, with autoimmunity (LRBA)
- Immunodysregulation, polyendocrinopathy + enteropathy, XL (FOXP3)
- Insulin resistance, severe, digenic (PPARG)
- Kanzaki disease (NAGA)
- Lactase deficiency, congenital (LCT)
- Lactase persistence + nonpersistence (MCM6)
- Leprechaunism (INSR)
- Lipodystrophy, congenital generalized, type 1 (AGPAT2)
- Lipodystrophy, congenital generalized, type 2 (BSCL2)
- Lipodystrophy, familial partial, type 2 (LMNA)
- Lipodystrophy, familial partial, type 3 (PPARG)
- Lipodystrophy, familial partial, type 4 (PLIN1)
- MEHMO [ment. ret., epilepsy, hypogonad./-genital., microceph., obesity] syndrome (EIF2S3)
- MODY, type I (HNF4A)
- MODY, type II (GCK)
- MODY, type III (HNF1A)
- MODY, type IV (PDX1)
- Malouf syndrome (LMNA)
- Mandibular hypoplasia, deafness, progeroid features, lipodystrophy syndrome (POLD1)
- Mandibuloacral dysplasia with type B lipodystrophy (ZMPSTE24)
- Mannosidosis, alpha-, types I + II (MAN2B1)
- Mannosidosis, beta (MANBA)
- Maturity-onset diabetes of the young 6 (NEUROD1)
- Maturity-onset diabetes of the young, type 10 (INS)
- Maturity-onset diabetes of the young, type 13 (KCNJ11)
- Maturity-onset diabetes of the young, type 14 (APPL1)
- Maturity-onset diabetes of the young, type VIII (CEL)
- McArdle disease (PYGM)
- Microcephaly, epilepsy + diabetes syndrome (IER3IP1)
- Microcephaly, short stature + impaired glucose metabolism 1 (TRMT10A)
- Microcephaly, short stature + impaired glucose metabolism 2 (PPP1R15B)
- Mitchell-Riley syndrome (RFX6)
- Monocarboxylate transporter 1 deficiency (SLC16A1)
- Mucopolysaccharidosis II (IDS)
- Mucopolysaccharidosis IVA (GALNS)
- Mucopolysaccharidosis Ih (IDUA)
- Mucopolysaccharidosis Ih/s (IDUA)
- Mucopolysaccharidosis Is (IDUA)
- Mucopolysaccharidosis type IIIA, Sanfilippo A (SHSH)
- Mucopolysaccharidosis type IIIB (Sanfilippo B (NAGLU)
- Mucopolysaccharidosis type IIIC, Sanfilippo C (HGSNAT)
- Mucopolysaccharidosis type IIID (GNS)
- Mucopolysaccharidosis type IVB, Morquio (GLB1)
- Mucopolysaccharidosis type VI, Maroteaux-Lamy (ARSB)
- Muscle glycogenosis (PHKA1)
- Neonatal diabetes + additional multi-organ autoimmunity [panelapp] (STAT3)
- Neonatal diabetes mellitus [MONDO:0016391] (NKX2-2)
- Neonatal diabetes, pancreatic agenesis and/or congenital heart defects [panelapp] (GATA4)
- Neuropathy, distal hereditary motor, type VC (BSCL2)
- Obesity, resistance to (PPARG)
- Obesity, severe (PPARG)
- Pancreatic + cerebellar agenesis (PTF1A)
- Pancreatic agenesis + congenital heart defects (GATA6)
- Pancreatic agenesis 1 (PDX1)
- Pancreatic agenesis 2 (PTF1A)
- Pentosuria (DCXR)
- Phosphoenolpyruvate carboxykinase deficiency, cytosolic (PCK1)
- Phosphoglycerate kinase 1 deficiency (PGK1)
- Phosphorylase kinase deficiency of liver + muscle, AR (PHKB)
- Polyglucosan body disease, adult form (GBE1)
- Polyglucosan body myopathy 1 with/-out immunodeficiency (RBCK1)
- Polyglucosan body myopathy 2 (GYG1)
- Primrose syndrome (ZBTB20)
- Pyruvate carboxylase deficiency (PC)
- Rabson-Mendenhall syndrome (NSR)
- Renal cysts + diabetes syndrome (HNF1B)
- Renal glucosuria (SLC5A2)
- Ribose 5-phosphate isomerase deficiency (RPIA)
- SHORT syndrome [partial lipodystrophy, Rieger anomaly + short stature] (PIK3R1)
- Schindler disease, type I + III (NAGA)
- Sialidosis, type I + II (NEU1)
- Silver spastic paraplegia syndrome (BSCL2)
- Stomatin-deficient cryohydrocytosis with neurologic defects (SLC2A1)
- Sucrase-isomaltase deficiency, congenital (SI)
- Syndromic neonatal diabetes, sev. developm. delay, hypotonia, cort. blindness, hearing loss (NKX2-2)
- Thiamine-responsive megaloblastic anemia syndrome (SLC19A2)
- Transaldolase deficiency (TALDO1)
- Trehalase deficiency (TREH)
- Type 2 diabetes mellitus (HNF1B)
- Type 2 diabetes mellitus, susceptibility to (NEUROD1)
- Wolcott-Rallison syndrome (EIF2AK3)
- Wolfram syndrome 1 (WFS1)
- Wolfram syndrome 2 (CISD2)
- Wolfram-like syndrome, AD (WFS1)
- Woodhouse-Sakati syndrome (DCAF17)
- AD
- AR
- XL
- XLR
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
Test-Stärken
- DAkkS-akkreditiertes Labor
- EU-Richtlinie für IVD in Umsetzung
- Qualitäts-kontrolliert arbeitendes Personal
- Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
- Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
- eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
- unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
- unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
- unsere umfassenden klinischen Aussagen
Testeinschränkungen
- Gene mit eingeschränkter Abdeckung werden gekennzeichnet
- Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
- es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
- die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
- Gen-Konversionen
- komplexe Inversionen
- Balancierte Translokationen
- Mitochondriale Varianten
- Repeat-Expansionen, sofern nicht anders dokumentiert
- nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
- niedriger Mosaik-Status
- Repeat-Blöcke von Mononukleotiden
- Indels >50bp (Insertionen-Deletionen)
- Deletionen oder Duplikationen einzelner Exons
- Varianten innerhalb von Pseudogenen
- die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde
Laboratory requirement
Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.
Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.
Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.
Die Untersuchung wird auch für Selbstzahler angeboten.